Researchers receive $460,000 NIH grant for brain imaging study

NewsGuard 100/100 Score

Michael Alosco, PhD, associate professor of neurology at Boston University School of Medicine (BUSM), and Gil Rabinovici, MD, professor of neurology and radiology at the University of California San Francisco (UCSF) have been awarded a two-year, $460,000 grant from the National Institute of Neurological Disorders and Stroke, which is part of the National Institutes of Health. Additional support for the study is provided by the Rainwater Charitable Foundation.

Alosco and Rabinovici will study the effectiveness of a second generation tau PET tracer (MK-6240) in hopes of detecting chronic traumatic encephalopathy (CTE) in living people. The study, "Focused Imaging for the Neurodegenerative Disease Chronic Traumatic Encephalopathy (FIND-CTE)," will involve 30 former National Football League players and 10 controls between the ages of 45-74. The Concussion Legacy Foundation will handle recruitment of the participants.

Repeated hits to the head, such as those from contact sports, have been associated with progressive brain diseases, including CTE. CTE is a progressive brain disease characterized by the presence of a protein called tau that presents uniquely from any other neurological disorder. However, to date, the only way to diagnosis CTE is through brain autopsy. This initial proof-of-concept study will attempt to identify a way to detect the tau protein of CTE prior to death using novel brain imaging methods.

This research will use a brain imaging technique called tau positron emission tomography to test the potential ability of a novel tau agent to detect the tau protein seen in CTE during life. If we can detect CTE during life, it will bring us closer to our ultimate goal of developing and testing potential treatments."

Michael Alosco, PhD, Associate Professor of Neurology, Boston University School of Medicine

Alosco is a licensed clinical neuropsychologist and the co-director of the NIA-funded Boston University Alzheimer's Disease Research Center Clinical Core and is also a lead investigator at the BU CTE Center. His research is devoted to studying the long-term effects of repetitive head impacts and biomarker development for CTE and related diseases. Alosco has more than 140 peer-reviewed publications, is the recipient of an NIH/NINDS K23 Award, is the Project Lead of an NIH-funded multisite U54 grant and serves as a PI and/or co-investigator on numerous federal and non-federal funded grants.

Those interested in signing up for the study can visit


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers identify the most harmful modifiable risk factors for dementia